About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Launches New Logo and Website

November 5, 2014

Click here to read more

Post navigation

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

Phosphagenics Newsletter November 2014

Related Posts

Mylan Arbitration Update – expert report on quantum of damages claimed filed

May 29, 2017

Media Coverage | Nine News

October 21, 2024October 21, 2024

Ethics Approval received for Phase III Clinical Trial

December 22, 2022December 22, 2022

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.